To test whether exosomal miR-125b-5p derived from MSC could enhance the therapeutic efficacy of anti-PD-1 treatment in colon cancer, we first generated miR-125b-5p-overexpressing MSCs and purified their exosomes. This evidence concerns the gene PDCD1 and malignant colon neoplasm.